Concentra Group Holdings Parent, Inc. · NYSE:CON

Concentra Group Holdings Parent — Q1 2025 Earnings Presentation

16 slides from Concentra Group Holdings Parent's earnings presentation, May 7, 2025

  1. Slide 1: Q1 2025 Results

    1 Quarter 2025 st Results May 7, 2025 ©2025 Concentra Inc. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to, financial guid

  3. Slide 3: Concentra At-a-Glance

    Concentra At-a-Glance Concentra is the largest provider of occupational health services in the United States by number of locations1, with a mission of improving the health of America’s workforce, one patient at a time KEY STATISTICS ROBUST FINANCIALS* 627 160 $1.9bn $383mm Occupational health Onsit

  4. Slide 4: We Continue to Deliver on Goals & Key Initiatives

    We Continue to Deliver on Goals & Key Initiatives Operational Strong Q1 performance with robust YoY growth in Revenue (+7.1%) and Adj. EBITDA (+6.8%), despite one less revenue day / Financial Positive year-over-year volume growth, including within Employer Services; trend has continued into Q2 2025

  5. Slide 5: Q1 2025 Performance

    Q1 2025 Performance Q1 2024 Q1 2025 YoY (∆) Commentary Facility Count (end of period) Occupational Health Centers 547 627 +80 Due to Nova acquisition (+67) and other M&A and de novos Onsite Health Clinics 151 160 +9 KPIs Visits per Day (“VPD”) 49.3k 50.9k 3.2% +0.6% Workers’ Compensation VPD 22.4k 2

  6. Slide 6: We Deliver High Quality Service to Employers and Patients Through Multiple Access Points

    We Deliver High Quality Service to Employers and Patients Through Multiple Access Points Occupational Health Onsite Health Centers Clinics Telemed 160 Virtual # of Facilities1 627 (excluding Pivot Onsite Innovations) 24/7 Each center serves hundreds of employers Each clinic dedicated to a single Cus

  7. Slide 7: Accelerating Growth Through the Acquisition of Pivot Onsite Innovations

    Accelerating Growth Through the Acquisition of Pivot Onsite Innovations Transaction Terms Key Considerations ▪ $55 million purchase price, subject to certain customary adjustments ▪ Immediately accretive to Concentra’s earnings; projected < 9x ▪ Expect to fund with cash-on-hand and available liquidi

  8. Slide 8: Highly Diverse Business with Strong Underlying Fundamentals and Minimal Stroke-of-the-Pen Risk

    We Have a Highly Diverse Business with Strong Underlying Fundamentals and Minimal Stroke-of-the-Pen Risk Attractive payor mix1 Broad geographic mix2 Texas Medicare & Other Urgent & Commercial 16% <1% 2% Workers’ Employer Compensation California Employers, insurance Remaining States 16% Services 52%

  9. Slide 9: Long-Demonstrated Track Record Of Navigating Broader Macroeconomic Turbulence

    We Have A Long-Demonstrated Track Record Of Navigating Broader Macroeconomic Turbulence ⚫ ~1% of revenue comes from government reimbursement (e.g., Medicare, Medicaid) Regulatory & ⚫ Workers’ Compensation reimbursement rates are pre-determined by state fee schedules or UCR guidelines, and not behold

  10. Slide 10: Balance Sheet & Capital Allocation Strategy

    Balance Sheet & Capital Allocation Strategy Heightened focus on acquisition integration and de-levering for remainder of 2025 Capital Allocation Strategy Net Leverage Liquidity (Net leverage as multiple of Adj. EBITDA1) ($ in millions) M&A and De Novos Strategic, impactful acquisitions (Nova, PHC, $

  11. Slide 11: Revised 2025 Full-Year Guidance

    Revised 2025 Full-Year Guidance Original FY 2025 Revised FY 2025 Guidance Commentary FY 2024 Actual YoY Growth (%) Guidance Guidance • Updating previous guidance from early March announcement Total Revenue $1,900.2mm $2.1bn $2.1bn – $2.15bn 10+% • Given strong start to 2025 and growth efforts, we ar

  12. Slide 12: Appendix

    Appendix ©2025 Concentra Inc. All rights reserved.

  13. Slide 13: Our Long-Term Financial Targets

    Our Long-Term Financial Targets Stable Revenue Consistent Robust Free Prudent Dividend Growth Profitability with Cash Flow2 Deleveraging Continued Generation Strategy Improvement Mid-to-High 20%+ >80% ~3.0x $0.0625 Single-digit growth Adjusted EBITDA Annual FCF Targeted net Quarterly cash margin1 co

  14. Slide 14: Reconciliation of Net Income to Adjusted EBITDA and Revenue

    Reconciliation of Net Income to Adjusted EBITDA and Revenue Three Months Ended Mar. 31, TTM Mar. 31, ($ in thousands) 2025 2024 2025 Revenue $500,752 $467,598 $1,933,346 Net Income $40,642 $50,279 $162,260 Income Tax Expense 13,254 15,137 57,613 Interest Expense 25,548 111 73,151 Interest Expense on

  15. Slide 15: Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance

    Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance Range ($ in millions) Low High Net Income Attributable to the Company $162 $173 Net Income Attributable to Non-Controlling Interests $6 $6 Net Income $168 $179 Income Tax Expense $56 $60 Interest Expense $108 $108 Stock Compensation Expense $

  16. Slide 16: Slide 16

Concentra Group Holdings Parent — Q1 2025 Earnings Presentation on 6ix